Anagenics Ltd (AN1) - Total Assets
Based on the latest financial reports, Anagenics Ltd (AN1) holds total assets worth AU$4.75 Million AUD (≈ $3.36 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Anagenics Ltd - Total Assets Trend (2006–2026)
This chart illustrates how Anagenics Ltd's total assets have evolved over time, based on quarterly financial data. Also see market cap of Anagenics Ltd for the company's overall valuation and market capitalisation.
Anagenics Ltd - Asset Composition Analysis
Current Asset Composition (June 2026)
Anagenics Ltd's total assets of AU$4.75 Million consist of 57.8% current assets and 42.2% non-current assets. Review AN1 liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 12.2% |
| Accounts Receivable | AU$805.41K | 17.0% |
| Inventory | AU$1.03 Million | 21.7% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$1.44K | 0.0% |
| Goodwill | AU$1.95 Million | 41.1% |
Asset Composition Trend (2006–2026)
This chart illustrates how Anagenics Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Anagenics Ltd share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Anagenics Ltd's current assets represent 57.8% of total assets in 2026, an increase from 50.1% in 2006.
- Cash Position: Cash and equivalents constituted 12.2% of total assets in 2026, down from 40.8% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, a decrease from 48.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 41.1% of total assets.
Anagenics Ltd Competitors by Total Assets
Key competitors of Anagenics Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Henkel AG & Co. KGaA vz. (Pref Shares)
XETRA:HEN3
|
Germany | €32.79 Billion |
|
Natura &Co Holding S.A.
SA:NTCO3
|
Brazil | R$34.86 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Hangzhou Haoyue Personal Care Co Ltd
SHG:605009
|
China | CN¥5.22 Billion |
|
Skin n Skin Co. Ltd
KQ:159910
|
Korea | ₩58.29 Billion |
|
Rigolleau SA
BA:RIGO
|
Argentina | AR$154.64 Billion |
|
ZOONO Group Ltd
AU:ZNO
|
Australia | AU$6.01 Million |
|
Star Combo Pharma Ltd
AU:S66
|
Australia | AU$46.99 Million |
Anagenics Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.27 | 0.89 | 5.89 |
| Quick Ratio | 3.30 | 0.44 | 4.56 |
| Cash Ratio | 0.00 | 0.18 | 3.51 |
| Working Capital | AU$2.22 Million | AU$-250.87K | AU$9.37 Million |
Anagenics Ltd - Advanced Valuation Insights
This section examines the relationship between Anagenics Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.40 |
| Latest Market Cap to Assets Ratio | 0.88 |
| Asset Growth Rate (YoY) | 15.7% |
| Total Assets | AU$4.75 Million |
| Market Capitalization | $4.18 Million USD |
Valuation Analysis
Near Book Valuation: The market values Anagenics Ltd's assets close to their book value (0.88x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Anagenics Ltd's assets grew by 15.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Anagenics Ltd (2006–2026)
The table below shows the annual total assets of Anagenics Ltd from 2006 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-06-30 | AU$4.75 Million ≈ $3.36 Million |
+15.73% |
| 2025-06-30 | AU$4.10 Million ≈ $2.90 Million |
-33.76% |
| 2024-06-30 | AU$6.19 Million ≈ $4.38 Million |
-44.28% |
| 2023-06-30 | AU$11.11 Million ≈ $7.86 Million |
-14.02% |
| 2022-06-30 | AU$12.92 Million ≈ $9.15 Million |
-2.77% |
| 2021-06-30 | AU$13.29 Million ≈ $9.41 Million |
-10.71% |
| 2020-06-30 | AU$14.89 Million ≈ $10.53 Million |
+52.04% |
| 2019-06-30 | AU$9.79 Million ≈ $6.93 Million |
+45.10% |
| 2018-06-30 | AU$6.75 Million ≈ $4.78 Million |
-20.35% |
| 2017-06-30 | AU$8.47 Million ≈ $5.99 Million |
+14.26% |
| 2016-06-30 | AU$7.41 Million ≈ $5.25 Million |
+20.61% |
| 2015-06-30 | AU$6.15 Million ≈ $4.35 Million |
-4.75% |
| 2014-06-30 | AU$6.45 Million ≈ $4.57 Million |
+7.69% |
| 2013-06-30 | AU$5.99 Million ≈ $4.24 Million |
+138.01% |
| 2012-06-30 | AU$2.52 Million ≈ $1.78 Million |
-10.76% |
| 2011-06-30 | AU$2.82 Million ≈ $2.00 Million |
-12.32% |
| 2010-06-30 | AU$3.22 Million ≈ $2.28 Million |
+163.26% |
| 2009-06-30 | AU$1.22 Million ≈ $864.96K |
-53.01% |
| 2008-06-30 | AU$2.60 Million ≈ $1.84 Million |
-44.83% |
| 2007-06-30 | AU$4.72 Million ≈ $3.34 Million |
-22.89% |
| 2006-06-30 | AU$6.11 Million ≈ $4.33 Million |
-- |
About Anagenics Ltd
Anagenics Limited engages in the health, wellness, and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the P… Read more